LIRUCITINIB
UNII TD3XJ8R5ZS

Substance Identification & Data

This profile provides standardized clinical and technical data for Lirucitinib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) TD3XJ8R5ZS.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2458115-78-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

TD3XJ8R5ZS

CAS Registry Number

2458115-78-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LIRUCITINIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C16H25N5OS

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

CPIJQOJWCQTORE-NSCUQIJASA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C215295

National Cancer Institute reference terminology for clinical and research data.

INN ID

3472

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

N([C@H]1CC[C@H](C[S@@](=O)(=N)CC)CC1)(c2ncnc3[nH]ccc32)C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lirucitinib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.